An interventional study of Transcutaneous Electrical Diaphragmatic Stimulation (TEDS) and Active Cycle of Breathing Techniques (ACBT) in COPD, sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to participants aged 40 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-07-23.
Sponsored by Riphah International University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 58 studies in Pulmonary Disease, Chronic Obstructive by Riphah International University — 18 open to participants now, 18 under way, none of them phase 3. Pulmonary Disease, Chronic Obstructive · Riphah International University.
Among the 58 studies in Pulmonary Disease, Chronic Obstructive by Riphah International University, this one is the 19th largest by planned enrollment of the 55 interventional ones that give a count, is one of 9 that started in 2025, is one of 55 with no phase, reaches primary completion later than 9 of the 17 other live ones, and was the 49th registered.
5,529 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 858 are open to participants now.
Browse Pulmonary Disease, Chronic Obstructive studies →18 of the 58 studies in Pulmonary Disease, Chronic Obstructive by Riphah International University are open now, in 1 country. Recruiting first, the newest first:
Riphah International University · Sites in Pakistan
Ages 40–60
Riphah International University · Sites in Pakistan
Ages 40–60 · Healthy volunteers
Riphah International University · Sites in Pakistan
Ages 40–50
Riphah International University · Sites in Pakistan
Ages 45–65
Riphah International University · Sites in Pakistan
Ages 35–50
By country, each count listing its studies:
Of the 560 Pulmonary Disease, Chronic Obstructive studies recruiting now, 307 (55%) set no upper age limit and 82 (15%) stop at 75 or younger; 30 take children under 18; 88 take healthy volunteers.
This study: 40 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
58 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 9 started in 2025.
This study's planned enrollment of 50 is below the median of 62 across 3,847 interventional studies indexed under Pulmonary Disease, Chronic Obstructive.
Median enrollment 46 across the 55 interventional studies, 140 across the 3 observational. Of the 37 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Riphah International University is the lead sponsor of 2,201 studies on the registry; 647 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 58 studies in Pulmonary Disease, Chronic Obstructive by Riphah International University, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The combined effects of transcutaneous electrical diaphragmatic stimulation (TEDS) and active cycle of breathing techniques (ACBTs) in patients with chronic obstructive pulmonary disease (COPD) conducted as a randomized controlled trial at Gulab Devi Hospital, the study involved 50 participants aged 40 to 60 with mild to moderate COPD. Participants were divided into two groups, one receiving both TEDS and ACBT, and the other receiving only ACBT. Over 12 weeks, improvements in lung function, oxygen saturation, exercise capacity, and quality of life were measured using spirometry, pulse oximetry, the 6-minute walk test, and the St. George's Respiratory Questionnaire. Both groups showed significant improvement, but the group receiving ACBT alone showed a slightly higher mean rank in some outcomes. The study concludes that while both interventions are beneficial, ACBT alone may offer more consistent improvements. It recommends including respiratory muscle assessments and combining interventions with education and exercise in future research.
This study investigates the effectiveness of combining transcutaneous electrical diaphragmatic stimulation (TEDS) with active cycle of breathing techniques (ACBTs) in the management of chronic obstructive pulmonary disease (COPD). COPD is a progressive respiratory condition characterized by airflow limitation, respiratory muscle weakness, and reduced quality of life. Non-pharmacological interventions like pulmonary rehabilitation, including TEDS and ACBT, have shown individual benefits in improving lung function and exercise tolerance in COPD patients. However, the combined effect of these interventions has not been extensively studied.
The research was designed as a randomized controlled trial conducted at Gulab Devi Hospital, Lahore. A total of 50 patients diagnosed with mild to moderate COPD, aged between 40 and 60 years, were recruited based on defined inclusion and exclusion criteria. Participants were randomly assigned to two groups: Group A received a combination of TEDS and ACBT, while Group B received ACBT alone. The intervention lasted for 12 weeks. TEDS was applied using specific settings-50Hz frequency, 300ms width, 6 seconds of stimulation followed by 5 seconds of rest. ACBT was administered through structured sessions involving breathing control, thoracic expansion, and forced expiratory techniques.
Outcome measures included forced expiratory volume in one second (FEV₁), forced vital capacity (FVC), FEV₁/FVC ratio, oxygen saturation (both at rest and post-exercise), six-minute walk test (6MWT) distance, and the St. George's Respiratory Questionnaire (SGRQ) for quality of life assessment. Data analysis was performed using SPSS version 25, and non-parametric tests were applied due to non-normal data distribution.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants receive transcutaneous electrical diaphragmatic stimulation (TEDS) along with active cycle of breathing techniques (ACBTs) daily for 12 weeks.
Device: Transcutaneous Electrical Diaphragmatic Stimulation (TEDS) · Behavioral: Active Cycle of Breathing Techniques (ACBT)
Participants receive only active cycle of breathing techniques (ACBTs) daily for 12 weeks.
Behavioral: Active Cycle of Breathing Techniques (ACBT)
TEDS was applied using surface electrodes placed over the diaphragm region. The stimulation protocol was set at 50 Hz frequency, 300 μs pulse width, with 6 seconds of stimulation followed by 5 seconds of rest, daily for 12 weeks. It was combined with ACBT sessions.
Also known as: Active Cycle of Breathing Techniques (ACBT)
ACBT sessions included breathing control, thoracic expansion exercises, and forced expiration techniques (huffing). Sessions were performed daily for 12 weeks to aid in secretion clearance and improve lung function.
Forced Expiratory Volume in 1 second (FEV1) using Spirometry
FEV1 measures the volume of air that can be forcibly exhaled in one second. It is a key indicator of airway obstruction and lung function in COPD patients.
Time frame: 12 weeks
Forced Vital Capacity (FVC) using Spirometry
FVC measures the total amount of air that can be forcibly exhaled after taking the deepest breath possible.
Time frame: 12 weeks
FEV1/FVC Ratio using Spirometry
using Spirometry
Time frame: 12 weeks
St. George's Respiratory Questionnaire (SGRQ)
Assesses health-related quality of life specific to respiratory diseases
Time frame: baseline and at 12 weeks post intervention
6-Minute Walk Test (6MWT)
Assesses functional exercise capacity.
Time frame: Baseline and at 12 weeks post-intervention
Oxygen Saturation after 6-Minute Walk Test (6MWT) via Pulse Oximetry
Evaluates oxygen desaturation during physical exertion, reflecting exercise tolerance and pulmonary reserve.
Time frame: Baseline and at 12 weeks post-intervention
Plan to share: No
No publications or documents are linked to this record.
Started May 2025 (actual). Primary completion is estimated for Oct 2025, 5 months after the start.
Of 1,099 non-industry interventional studies with no phase under Pulmonary Disease, Chronic Obstructive, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 5 months is below that.
Counting every sponsor, half of 1,187 studies reached it within 22 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pulmonary Disease, Chronic Obstructive →
Riphah International University →